AI Article Synopsis

  • Venezuelan, eastern, and western equine encephalitis viruses are dangerous viruses that can cause severe illness in both horses and humans, but there are currently no approved vaccines or antiviral treatments for them.
  • Vaccine development requires FDA approval based on animal models that accurately reflect human disease, but existing mouse models do not do so effectively, as they result in different disease outcomes than in humans.
  • Recent studies indicate that using hamsters as a model for testing vaccines and therapies against these viruses is also ineffective, as their disease symptoms do not align with those seen in humans or non-human primates.

Article Abstract

Venezuelan (VEE), eastern (EEE), and western (WEE) equine encephalitis viruses are encephalitic New World alphaviruses that cause periodic epizootic and epidemic outbreaks in horses and humans that may cause severe morbidity and mortality. Currently there are no FDA-licensed vaccines or effective antiviral therapies. Each year, there are a limited number of human cases of encephalitic alphaviruses; thus, licensure of a vaccine or therapeutic would require approval under the FDA animal rule. Approval under the FDA animal rule requires the disease observed in the animal model to recapitulate what is observed in humans. Currently, initial testing of vaccines and therapeutics is performed in the mouse model. Unfortunately, alphavirus disease manifestations in a mouse do not faithfully recapitulate human disease; the VEEV mouse model is lethal whereas in humans VEEV is rarely lethal. In an effort to identify a more appropriate small animal model, we evaluated hamsters in an aerosol exposure model of encephalitic alphavirus infection. The pathology, lethality, and viremia observed in the infected hamsters was inconsistent with what is observed in NHP models and humans. These data suggest that hamsters are not an appropriate model for encephalitic alphaviruses to test vaccines or potential antiviral therapies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11130913PMC
http://dx.doi.org/10.3390/mps7030042DOI Listing

Publication Analysis

Top Keywords

encephalitic alphaviruses
16
aerosol exposure
8
antiviral therapies
8
approval fda
8
fda animal
8
animal rule
8
animal model
8
mouse model
8
model encephalitic
8
model
7

Similar Publications

The sticky business of Alphavirus capsid-host interactions.

Trends Microbiol

December 2024

Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address:

Alphaviruses are a serious threat to global health and can cause lethal encephalitic or arthritogenic disease in humans and animals. As there are no licensed antivirals, it is critical to improve our understanding of alphavirus interactions with the host cell. Here, we focus on the essential alphavirus protein capsid.

View Article and Find Full Text PDF

Madariaga virus (MADV) and Venezuelan equine encephalitis virus (VEEV) are emerging arboviruses affecting rural and remote areas of Latin America. However, clinical and epidemiologic reports are limited, and outbreaks are occurring at an increasing frequency. We addressed the data gap by analyzing all available clinical and epidemiologic data of MADV and VEEV infections recorded since 1961 in Panama.

View Article and Find Full Text PDF

The VLDLR entry receptor is required for the pathogenesis of multiple encephalitic alphaviruses.

Cell Rep

October 2024

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO 63110, USA; Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, Saint Louis, MO 63110, USA. Electronic address:

Article Synopsis
  • VLDLR has been identified as a receptor for several alphaviruses, including Western equine encephalitis virus (WEEV), and may play a role in their infection process.
  • Research shows that mice lacking VLDLR have reduced susceptibility to WEEV, EEEV, and Semliki Forest virus (SFV), indicating its importance in alphavirus pathogenesis.
  • The findings suggest that targeting VLDLR could be a potential strategy for developing treatments against various alphavirus infections.
View Article and Find Full Text PDF
Article Synopsis
  • Venezuelan equine encephalitis virus (VEEV) is a mosquito-borne virus found in Central and South America, causing disease in horses and humans during epidemics.
  • Different transmission mechanisms exist for endemic VEEV (via Culex mosquitoes and rodents) versus epidemic VEEV (via mosquitoes and horses), with mutations in viral strains leading to epizootic outbreaks.
  • The study reveals that specific RNA structures in the VEEV genome affect its ability to replicate in macrophages, highlighting the importance of genetic mutations and RNA-binding proteins in the virus's emergence and adaptation.
View Article and Find Full Text PDF
Article Synopsis
  • Western equine encephalitis virus (WEEV) used to cause significant outbreaks in humans and horses but has become less virulent over time, raising questions about the reasons for this change and the potential for re-emergence of deadly strains.
  • Researchers identified protocadherin 10 (PCDH10) as a key receptor for WEEV, which ancient strains could bind to, while contemporary strains show reduced binding abilities indicating a shift in the virus’s host adaptation.
  • The study suggests that PCDH10 not only facilitates infection in neurons but also that a soluble form can protect against WEEV, offering insights for future medical treatments and risk assessments of the virus.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!